We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A series of indicators to inform safer prescribing practice to help pharmacists, clinicians and patients review prescribed medication and prevent harm.
Prescribing by BNF Section by CCG in England up to March 2018.
Details of how Marketing Authorisation Holders can provide information on planned or potential future submissions, to the MHRA.
Prescribing by BNF Section by CCG in England up to September 2017
Prescribing by BNF Section by CCG in England up to December 2017
The Commission on Human Medicines (CHM) has endorsed changes to isotretinoin prescribing guidance. In addition, CHM is seeking further information from dermatology services who prescribe isotretinoin to inform any future changes to current risk minimisation measures.
Prescribing by BNF Section by CCG in England up to March 2017.
Prescribing by BNF Section by CCG in England up to June 2017
Prescribing by BNF Section by CCG in England up to December 2015.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).